Shilpa Medicare informs about company updates

17 Mar 2018 Evaluate

Shilpa Medicare has informed that the US FDA intimated the Company that based on its inspection from 11th November to 30th November 2017 the Unit of the Company located at S-20 TO S-24/A, pharmaceutical Formulations SEZ TSIIC, Green Industrial Park, Polepally, Jadcherla, Mahabubnagar, Telangana, India, has been determined that the inspection classification of this facility is VAI.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

323.70 9.05 (2.88%)
20-Mar-2026 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.20
Dr. Reddys Lab 1295.00
Cipla 1260.65
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×